Categories AlphaGraphs, Earnings, Technology

Infographic: Microsoft (MSFT) stock gains as Q1 earnings top expectations

Microsoft Corp. (NASDAQ: MSFT) on Tuesday reported higher revenues and earnings for the first quarter of 2021. The results also topped expectations and the software giant’s shares rose during the extended trading session.

Microsoft Q1 2021 earnings infographic

At $37.2 billion, first-quarter revenues were up 12% from the comparable period of fiscal 2020 and above analysts’ forecast. Server products and cloud services revenue avanced 22%, with Azure revenue gaining 48%.

Net income came in at $13.9 billion or $1.82 per share in September-quarter, compared to $10.7 billion or $1.38 per share in the first quarter of 2020. The bottom-line also came in above estimates.

Microsoft Azure Revenue Growth Trend

Commenting on the results, Microsoft’s CEO Satya Nadella said, “The next decade of economic performance for every business will be defined by the speed of their digital transformation. We are innovating across our full modern tech stack to help our customers in every industry improve time to value, increase agility, and reduce costs.”


Read management/analysts’ comments on Microsoft’s Q1 earnings


Microsoft’s shares gained on Tuesday evening as the strong results spurred a rally, after closing the regular session higher.

  • microsoft Q2 2020 earnings infographic
  • Microsoft Q1 profit jumps 21%, tops estimates
  • Microsoft earnings review

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top